The influenza virus, SARS-CoV-2, and the airways: Clarification for the otorhinolaryngologist.
Identifieur interne : 000409 ( Main/Exploration ); précédent : 000408; suivant : 000410The influenza virus, SARS-CoV-2, and the airways: Clarification for the otorhinolaryngologist.
Auteurs : L. De Gabory [France] ; A. Alharbi [France] ; M. Kérimian [France] ; M-E Lafon [France]Source :
- European annals of otorhinolaryngology, head and neck diseases [ 1879-730X ] ; 2020.
Descripteurs français
- KwdFr :
- ARN viral (analyse), Aérosols (MeSH), Betacoronavirus (génétique), Betacoronavirus (pathogénicité), Grippe humaine (transmission), Humains (MeSH), Infections à coronavirus (transmission), Muqueuse respiratoire (virologie), Orthomyxoviridae (génétique), Orthomyxoviridae (pathogénicité), Oto-rhino-laryngologie (MeSH), Pandémies (MeSH), Pneumopathie virale (transmission), Sécrétions corporelles (virologie).
- MESH :
- analyse : ARN viral.
- génétique : Betacoronavirus, Orthomyxoviridae.
- pathogénicité : Betacoronavirus, Orthomyxoviridae.
- virologie : Muqueuse respiratoire, Sécrétions corporelles.
- Aérosols, Grippe humaine, Humains, Infections à coronavirus, Oto-rhino-laryngologie, Pandémies, Pneumopathie virale.
English descriptors
- KwdEn :
- Aerosols (MeSH), Betacoronavirus (genetics), Betacoronavirus (pathogenicity), Bodily Secretions (virology), Coronavirus Infections (transmission), Humans (MeSH), Influenza, Human (transmission), Orthomyxoviridae (genetics), Orthomyxoviridae (pathogenicity), Otolaryngology (MeSH), Pandemics (MeSH), Pneumonia, Viral (transmission), RNA, Viral (analysis), Respiratory Mucosa (virology).
- MESH :
- chemical , analysis : RNA, Viral.
- chemical : Aerosols.
- genetics : Betacoronavirus, Orthomyxoviridae.
- pathogenicity : Betacoronavirus, Orthomyxoviridae.
- transmission : Coronavirus Infections, Influenza, Human, Pneumonia, Viral.
- virology : Bodily Secretions, Respiratory Mucosa.
- Humans, Otolaryngology, Pandemics.
Abstract
The influenza virus and SARS-CoV-2 cause trivial upper and severe lower respiratory infections (Influenza virus 290,000 to 650,000 deaths/year). These viruses come into contact with the airways either by direct projection, by secondary inhalation of airborne droplets, or by handling (fomites). The objective of this article is to clarify the mechanisms of production and penetration of droplets of secretions emitted during all expiratory phenomena likely to transport these viruses and come into contact with the respiratory mucosa. The droplets>5μm follow the laws of ballistics, those<5μm follow Brownian motion and remain suspended in the air. The aerosols of droplets are very heterogeneous whether the subject is healthy or sick. During an infectious period, not all droplets contain viral RNA. If these RNAs are detectable around patients, on surfaces, and in the ambient air at variable distances according to the studies (from 0.5m to beyond the patient's room), this is without prejudice to the infectious nature (viability) of the virus and the minimum infectious dose. There is a time lag between the patient's infectious period and that of RNA detection for both viruses. Subsequently, the inhaled particles must meet the laws of fluid dynamics (filtration) to settle in the respiratory tree. All of this partly explains the contagiousness and the clinical expression of these two viruses from the olfactory cleft to the alveoli.
DOI: 10.1016/j.anorl.2020.05.015
PubMed: 32507410
PubMed Central: PMC7261469
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The influenza virus, SARS-CoV-2, and the airways: Clarification for the otorhinolaryngologist.</title><author><name sortKey="De Gabory, L" sort="De Gabory, L" uniqKey="De Gabory L" first="L" last="De Gabory">L. De Gabory</name><affiliation wicri:level="3"><nlm:affiliation>Department of ENT and Head & Neck Surgery, Bordeaux University Hospital, France; University Bordeaux, 33000 Bordeaux, France. Electronic address: ludovic.de-gabory@chu-bordeaux.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of ENT and Head & Neck Surgery, Bordeaux University Hospital, France; University Bordeaux, 33000 Bordeaux</wicri:regionArea><placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region><region type="old region" nuts="2">Aquitaine</region><settlement type="city">Bordeaux</settlement></placeName></affiliation></author><author><name sortKey="Alharbi, A" sort="Alharbi, A" uniqKey="Alharbi A" first="A" last="Alharbi">A. Alharbi</name><affiliation wicri:level="1"><nlm:affiliation>Department of ENT and Head & Neck Surgery, Bordeaux University Hospital, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of ENT and Head & Neck Surgery, Bordeaux University Hospital</wicri:regionArea><wicri:noRegion>Bordeaux University Hospital</wicri:noRegion><wicri:noRegion>Bordeaux University Hospital</wicri:noRegion></affiliation></author><author><name sortKey="Kerimian, M" sort="Kerimian, M" uniqKey="Kerimian M" first="M" last="Kérimian">M. Kérimian</name><affiliation wicri:level="1"><nlm:affiliation>Department of ENT and Head & Neck Surgery, Bordeaux University Hospital, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of ENT and Head & Neck Surgery, Bordeaux University Hospital</wicri:regionArea><wicri:noRegion>Bordeaux University Hospital</wicri:noRegion><wicri:noRegion>Bordeaux University Hospital</wicri:noRegion></affiliation></author><author><name sortKey="Lafon, M E" sort="Lafon, M E" uniqKey="Lafon M" first="M-E" last="Lafon">M-E Lafon</name><affiliation wicri:level="1"><nlm:affiliation>Department of Virology and Biological Monitoring Unit, Bordeaux University Hospital, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Virology and Biological Monitoring Unit, Bordeaux University Hospital</wicri:regionArea><wicri:noRegion>Bordeaux University Hospital</wicri:noRegion><wicri:noRegion>Bordeaux University Hospital</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32507410</idno><idno type="pmid">32507410</idno><idno type="doi">10.1016/j.anorl.2020.05.015</idno><idno type="pmc">PMC7261469</idno><idno type="wicri:Area/Main/Corpus">000F24</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000F24</idno><idno type="wicri:Area/Main/Curation">000F24</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000F24</idno><idno type="wicri:Area/Main/Exploration">000F24</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The influenza virus, SARS-CoV-2, and the airways: Clarification for the otorhinolaryngologist.</title><author><name sortKey="De Gabory, L" sort="De Gabory, L" uniqKey="De Gabory L" first="L" last="De Gabory">L. De Gabory</name><affiliation wicri:level="3"><nlm:affiliation>Department of ENT and Head & Neck Surgery, Bordeaux University Hospital, France; University Bordeaux, 33000 Bordeaux, France. Electronic address: ludovic.de-gabory@chu-bordeaux.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of ENT and Head & Neck Surgery, Bordeaux University Hospital, France; University Bordeaux, 33000 Bordeaux</wicri:regionArea><placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region><region type="old region" nuts="2">Aquitaine</region><settlement type="city">Bordeaux</settlement></placeName></affiliation></author><author><name sortKey="Alharbi, A" sort="Alharbi, A" uniqKey="Alharbi A" first="A" last="Alharbi">A. Alharbi</name><affiliation wicri:level="1"><nlm:affiliation>Department of ENT and Head & Neck Surgery, Bordeaux University Hospital, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of ENT and Head & Neck Surgery, Bordeaux University Hospital</wicri:regionArea><wicri:noRegion>Bordeaux University Hospital</wicri:noRegion><wicri:noRegion>Bordeaux University Hospital</wicri:noRegion></affiliation></author><author><name sortKey="Kerimian, M" sort="Kerimian, M" uniqKey="Kerimian M" first="M" last="Kérimian">M. Kérimian</name><affiliation wicri:level="1"><nlm:affiliation>Department of ENT and Head & Neck Surgery, Bordeaux University Hospital, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of ENT and Head & Neck Surgery, Bordeaux University Hospital</wicri:regionArea><wicri:noRegion>Bordeaux University Hospital</wicri:noRegion><wicri:noRegion>Bordeaux University Hospital</wicri:noRegion></affiliation></author><author><name sortKey="Lafon, M E" sort="Lafon, M E" uniqKey="Lafon M" first="M-E" last="Lafon">M-E Lafon</name><affiliation wicri:level="1"><nlm:affiliation>Department of Virology and Biological Monitoring Unit, Bordeaux University Hospital, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Virology and Biological Monitoring Unit, Bordeaux University Hospital</wicri:regionArea><wicri:noRegion>Bordeaux University Hospital</wicri:noRegion><wicri:noRegion>Bordeaux University Hospital</wicri:noRegion></affiliation></author></analytic><series><title level="j">European annals of otorhinolaryngology, head and neck diseases</title><idno type="eISSN">1879-730X</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aerosols (MeSH)</term><term>Betacoronavirus (genetics)</term><term>Betacoronavirus (pathogenicity)</term><term>Bodily Secretions (virology)</term><term>Coronavirus Infections (transmission)</term><term>Humans (MeSH)</term><term>Influenza, Human (transmission)</term><term>Orthomyxoviridae (genetics)</term><term>Orthomyxoviridae (pathogenicity)</term><term>Otolaryngology (MeSH)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (transmission)</term><term>RNA, Viral (analysis)</term><term>Respiratory Mucosa (virology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>ARN viral (analyse)</term><term>Aérosols (MeSH)</term><term>Betacoronavirus (génétique)</term><term>Betacoronavirus (pathogénicité)</term><term>Grippe humaine (transmission)</term><term>Humains (MeSH)</term><term>Infections à coronavirus (transmission)</term><term>Muqueuse respiratoire (virologie)</term><term>Orthomyxoviridae (génétique)</term><term>Orthomyxoviridae (pathogénicité)</term><term>Oto-rhino-laryngologie (MeSH)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (transmission)</term><term>Sécrétions corporelles (virologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>RNA, Viral</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Aerosols</term></keywords><keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>ARN viral</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Betacoronavirus</term><term>Orthomyxoviridae</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Betacoronavirus</term><term>Orthomyxoviridae</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Betacoronavirus</term><term>Orthomyxoviridae</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Betacoronavirus</term><term>Orthomyxoviridae</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Coronavirus Infections</term><term>Influenza, Human</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Muqueuse respiratoire</term><term>Sécrétions corporelles</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Bodily Secretions</term><term>Respiratory Mucosa</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Otolaryngology</term><term>Pandemics</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Aérosols</term><term>Grippe humaine</term><term>Humains</term><term>Infections à coronavirus</term><term>Oto-rhino-laryngologie</term><term>Pandémies</term><term>Pneumopathie virale</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The influenza virus and SARS-CoV-2 cause trivial upper and severe lower respiratory infections (Influenza virus 290,000 to 650,000 deaths/year). These viruses come into contact with the airways either by direct projection, by secondary inhalation of airborne droplets, or by handling (fomites). The objective of this article is to clarify the mechanisms of production and penetration of droplets of secretions emitted during all expiratory phenomena likely to transport these viruses and come into contact with the respiratory mucosa. The droplets>5μm follow the laws of ballistics, those<5μm follow Brownian motion and remain suspended in the air. The aerosols of droplets are very heterogeneous whether the subject is healthy or sick. During an infectious period, not all droplets contain viral RNA. If these RNAs are detectable around patients, on surfaces, and in the ambient air at variable distances according to the studies (from 0.5m to beyond the patient's room), this is without prejudice to the infectious nature (viability) of the virus and the minimum infectious dose. There is a time lag between the patient's infectious period and that of RNA detection for both viruses. Subsequently, the inhaled particles must meet the laws of fluid dynamics (filtration) to settle in the respiratory tree. All of this partly explains the contagiousness and the clinical expression of these two viruses from the olfactory cleft to the alveoli.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32507410</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-730X</ISSN><JournalIssue CitedMedium="Internet"><Volume>137</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Sep</Month></PubDate></JournalIssue><Title>European annals of otorhinolaryngology, head and neck diseases</Title><ISOAbbreviation>Eur Ann Otorhinolaryngol Head Neck Dis</ISOAbbreviation></Journal><ArticleTitle>The influenza virus, SARS-CoV-2, and the airways: Clarification for the otorhinolaryngologist.</ArticleTitle><Pagination><MedlinePgn>291-296</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1879-7296(20)30139-3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.anorl.2020.05.015</ELocationID><Abstract><AbstractText>The influenza virus and SARS-CoV-2 cause trivial upper and severe lower respiratory infections (Influenza virus 290,000 to 650,000 deaths/year). These viruses come into contact with the airways either by direct projection, by secondary inhalation of airborne droplets, or by handling (fomites). The objective of this article is to clarify the mechanisms of production and penetration of droplets of secretions emitted during all expiratory phenomena likely to transport these viruses and come into contact with the respiratory mucosa. The droplets>5μm follow the laws of ballistics, those<5μm follow Brownian motion and remain suspended in the air. The aerosols of droplets are very heterogeneous whether the subject is healthy or sick. During an infectious period, not all droplets contain viral RNA. If these RNAs are detectable around patients, on surfaces, and in the ambient air at variable distances according to the studies (from 0.5m to beyond the patient's room), this is without prejudice to the infectious nature (viability) of the virus and the minimum infectious dose. There is a time lag between the patient's infectious period and that of RNA detection for both viruses. Subsequently, the inhaled particles must meet the laws of fluid dynamics (filtration) to settle in the respiratory tree. All of this partly explains the contagiousness and the clinical expression of these two viruses from the olfactory cleft to the alveoli.</AbstractText><CopyrightInformation>Copyright © 2020 Elsevier Masson SAS. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Gabory</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of ENT and Head & Neck Surgery, Bordeaux University Hospital, France; University Bordeaux, 33000 Bordeaux, France. Electronic address: ludovic.de-gabory@chu-bordeaux.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alharbi</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of ENT and Head & Neck Surgery, Bordeaux University Hospital, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kérimian</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of ENT and Head & Neck Surgery, Bordeaux University Hospital, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lafon</LastName><ForeName>M-E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Virology and Biological Monitoring Unit, Bordeaux University Hospital, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Eur Ann Otorhinolaryngol Head Neck Dis</MedlineTA><NlmUniqueID>101531465</NlmUniqueID><ISSNLinking>1879-7296</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000336">Aerosols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000336" MajorTopicYN="N">Aerosols</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012634" MajorTopicYN="N">Bodily Secretions</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000635" MajorTopicYN="Y">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000635" MajorTopicYN="Y">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009975" MajorTopicYN="N">Orthomyxoviridae</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010036" MajorTopicYN="Y">Otolaryngology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000635" MajorTopicYN="Y">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020545" MajorTopicYN="N">Respiratory Mucosa</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Airborne particle</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Influenza virus</Keyword><Keyword MajorTopicYN="N">Respiratory infection</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32507410</ArticleId><ArticleId IdType="pii">S1879-7296(20)30139-3</ArticleId><ArticleId IdType="doi">10.1016/j.anorl.2020.05.015</ArticleId><ArticleId IdType="pmc">PMC7261469</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Aquitaine</li><li>Nouvelle-Aquitaine</li></region><settlement><li>Bordeaux</li></settlement></list><tree><country name="France"><region name="Nouvelle-Aquitaine"><name sortKey="De Gabory, L" sort="De Gabory, L" uniqKey="De Gabory L" first="L" last="De Gabory">L. De Gabory</name></region><name sortKey="Alharbi, A" sort="Alharbi, A" uniqKey="Alharbi A" first="A" last="Alharbi">A. Alharbi</name><name sortKey="Kerimian, M" sort="Kerimian, M" uniqKey="Kerimian M" first="M" last="Kérimian">M. Kérimian</name><name sortKey="Lafon, M E" sort="Lafon, M E" uniqKey="Lafon M" first="M-E" last="Lafon">M-E Lafon</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000409 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000409 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32507410
|texte= The influenza virus, SARS-CoV-2, and the airways: Clarification for the otorhinolaryngologist.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32507410" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |